Prediction of tumor recurrence and therapy monitoring using ultrasound-guided photoacoustic imaging

Theranostics

Volumn 5, Issue 3, 2015, Pages 289-301

  Mallidi, Srivalleesha ^a   Watanabe, Kohei ^a,b   Timerman, Dmitriy ^a   Schoenfeld, David ^a   Hasan, Tayyaba ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Canon USA Inc   (United States)

Author keywords

Photoacoustic imaging; Photodynamic therapy

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD OXYGEN TENSION; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHOTOACOUSTICS; PHOTODYNAMIC THERAPY; PREDICTION; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR XENOGRAFT; ANIMAL; CHEMISTRY; DISEASE MODEL; DRUG MONITORING; ECHOGRAPHY; PHOTOCHEMOTHERAPY; PROCEDURES; PROGNOSIS; RECURRENT DISEASE;

HEMOGLOBIN; OXYGEN;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG MONITORING; FEMALE; GLIOBLASTOMA; HEMOGLOBINS; MICE; OXYGEN; PHOTOACOUSTIC TECHNIQUES; PHOTOCHEMOTHERAPY; PROGNOSIS; RECURRENCE; ULTRASONOGRAPHY;

EID: 84924376924     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.10155     Document Type: Article

References (50)

1. Marusyk A, Almendro V, Polyak K. Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer. 2012; 12: 323-34.
2. Norden AD, Young GS, Setayesh K, Muzikansky A, Klufas R, Ross GL, et al. Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence. Neurology. 2008; 70: 779-87.
3. Weller M, Cloughesy T, Perry JR, Wick W. Standards of care for treatment of recurrent glioblastoma--are we there yet? Neuro Oncol. 2013; 15: 4-27.
4. Vartanian A, Singh SK, Agnihotri S, Jalali S, Burrell K, Aldape KD, et al. GBM's multifaceted landscape: highlighting regional and microenvironmental heterogeneity. Neuro Oncol. 2014; 16: 1167-75.
5. Zhao B, Schwartz LH, Larson SM. Imaging surrogates of tumor response to therapy: anatomic and functional biomarkers. J Nucl Med. 2009; 50: 239-49.
6. Tirkes T, Hollar MA, Tann M, Kohli MD, Akisik F, Sandrasegaran K. Response criteria in oncologic imaging: review of traditional and new criteria. Radiographics. 2013; 33: 1323-41.
7. Celli JP, Spring BQ, Rizvi I, Evans CL, Samkoe KS, Verma S, et al. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. Chem Rev. 2010; 110: 2795-838.
8. Wilson BC, Patterson MS, Lilge L. Implicit and explicit dosimetry in photodynamic therapy: a New paradigm. Lasers Med Sci. 1997; 12: 182-99.
9. Rai P, Mallidi S, Zheng X, Rahmanzadeh R, Mir Y, Elrington S, et al. Development and applications of photo-triggered theranostic agents. Adv Drug Deliv Rev. 2010; 62: 1094-124.
10. Solban N, Rizvi I, Hasan T. Targeted photodynamic therapy. Lasers Surg Med. 2006; 38: 522-31.
11. Bechet D, Mordon SR, Guillemin F, Barberi-Heyob MA. Photodynamic therapy of malignant brain tumours: A complementary approach to conventional therapies. Cancer Treat Rev. 2014; 40: 229-41.
12. Huggett MT, Jermyn M, Gillams A, Illing R, Mosse S, Novelli M, et al. Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer. Br J Cancer. 2014; 110: 1698-704.
13. Woodhams JH, MacRobert AJ, Bown SG. The role of oxygen monitoring during photodynamic therapy and its potential for treatment dosimetry. Photochem Photobiol Sci. 2007; 6: 1246-56.
14. Höckel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst. 2001; 93: 266-76.
15. Pogue BW, Chen B, Zhou X, Hoopes PJ. Analysis of sampling volume and tissue heterogeneity on the in vivo detection of fluorescence. J Biomed Opt. 2005; 10: 41206-. 16. Sitnik TM, Hampton JA, Henderson BW. Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate. Br J Cancer. 1998; 77: 1386-94.
16. Sitnik TM, Hampton JA, Henderson BW. Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate. Br J Cancer. 1998; 77: 1386-94.
17. Coutier S, Bezdetnaya LN, Foster TH, Parache R-M, Guillemin F. Effect of irradiation fluence rate on the efficacy of photodynamic therapy and tumor oxygenation in meta-tetra (hydroxyphenyl) chlorin (mTHPC)-sensitized HT29 xenografts in nude mice. Radiat Res. 2002; 158: 339-45.
18. Yu G, Durduran T, Zhou C, Wang H-W, Putt ME, Saunders HM, et al. Noninvasive monitoring of murine tumor blood flow during and after photodynamic therapy provides early assessment of therapeutic efficacy. Clin Cancer Res. 2005; 11: 3543-52.
19. Wang H-W, Putt ME, Emanuele MJ, Shin DB, Glatstein E, Yodh AG, et al. Treatment-induced changes in tumor oxygenation predict photodynamic therapy outcome. Cancer Res. 2004; 64: 7553-61.
20. Pham TH, Hornung R, Berns MW, Tadir Y, Tromberg BJ. Monitoring tumor response during photodynamic therapy using near-infrared photon-migration spectroscopy. Photochem Photobiol. 2001; 73: 669-77.
21. Robinson DJ, Karakullukçu MB, Kruijt B, Kanick SC, van Veen RPL, Amelink A, et al. Optical spectroscopy to guide photodynamic therapy of head and neck tumors. IEEE J Select Topics Quantum Electron. 2010; 16: 854-62.
22. Gross S, Gilead A, Scherz A, Neeman M, Salomon Y. Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI. Nat Med. 2003; 9: 1327-31.
23. Wang LV. Prospects of photoacoustic tomography. Med Phys. 2008; 35: 5758.
24. Ntziachristos V, Razansky D. Molecular Imaging by Means of Multispectral Optoacoustic Tomography (MSOT). Chem Rev. 2010; 110: 2783-94.
25. Mallidi S, Luke GP, Emelianov SY. Photoacoustic imaging in cancer detection, diagnosis, and treatment guidance. Trends Biotechnol. 2011; 29: 213-21.
26. Needles A, Heinmiller A, Sun J, Theodoropoulos C, Bates D, Hirson D, et al. Development and initial application of a fully integrated photoacoustic micro-ultrasound system. IEEE Trans Ultrason Ferroelectr Freq Control. 2013; 60: 888-97.
27. Chen B, Pogue BW, Hoopes PJ, Hasan T. Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy. Int J Radiat Oncol Biol Phys. 2005; 61: 1216-26.
28. Osaki T, Takagi S, Hoshino Y, Okumura M, Fujinaga T. Antitumor effects and blood flow dynamics after photodynamic therapy using benzoporphyrin derivative monoacid ring A in KLN205 and LM8 mouse tumor models. Cancer Lett. 2007; 248: 47-57.
29. Becker TL, Paquette AD, Keymel KR, Henderson BW, Sunar U. Monitoring blood flow responses during topical ALA-PDT. Biomed Opt Express. 2011; 2: 123-30.
30. Mallidi S, Anbil S, Lee S, Manstein D, Elrington S, Kositratna G, et al. Photosensitizer fluorescence and singlet oxygen luminescence as dosimetric predictors of topical 5-aminolevulinic acid photodynamic therapy induced clinical erythema. J Biomed Opt. 2014; 19: 028001.
31. Gerling M, Zhao Y, Nania S, Norberg KJ, Verbeke CS, Englert B, et al. Real-time assessment of tissue hypoxia in vivo with combined photoacoustics and high-frequency ultrasound. Theranostics. 2014; 4: 604-13.
32. van Geel IP, Oppelaar H, Rijken PF, Bernsen HJ, Hagemeier NE, van der Kogel AJ, et al. Vascular perfusion and hypoxic areas in RIF-1 tumours after photodynamic therapy. Br J Cancer. 1996; 73: 288-93.
33. Maas AL, Carter SL, Wileyto EP, Miller J, Yuan M, Yu G, et al. Tumor vascular microenvironment determines responsiveness to photodynamic therapy. Cancer Res. 2012; 72: 2079-88.
34. Busch TM, Wileyto EP, Emanuele MJ, Del Piero F, Marconato L, Glatstein E, et al. Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen. Cancer Res. 2002; 62: 7273-9.
35. Celli JP, Solban N, Liang A, Pereira SP, Hasan T. Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines. Lasers Surg Med. 2011; 43: 565-74.
36. Pech O, Behrens A, May A, Nachbar L, Gossner L, Rabenstein T, et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut. 2008; 57: 1200-6.
37. Ashkenazi S. Photoacoustic lifetime imaging of dissolved oxygen using methylene blue. J Biomed Opt. 2010; 15: 040501.
38. Hirao A, Sato S, Saitoh D, Shinomiya N, Ashida H, Obara M. In vivo photoacoustic monitoring of photosensitizer distribution in burned skin for antibacterial photodynamic therapy. Photochem Photobiol. 2010; 86: 426-30.
39. Ho CJH, Balasundaram G, Driessen W, McLaren R, Wong CL, Dinish US, et al. Multifunctional photosensitizer-based contrast agents for photoacoustic imaging. Sci Rep. 2014; 4: 5342-6.
40. Jeon M, Song W, Huynh E, Kim J, Kim J, Helfield BL, et al. Methylene blue microbubbles as a model dual-modality contrast agent for ultrasound and activatable photoacoustic imaging. J Biomed Opt. 2014; 19: 16005.
41. Lovell J, Jin CS, Huynh EE, Jin H, Kim C, Rubinstein J, et al. Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nat Mater. 2011; 10: 324-32.
42. Huang P, Lin J, Wang S, Zhou Z, Li Z, Wang Z, et al. Photosensitizer-conjugated silica-coated gold nanoclusters for fluorescence imaging-guided photodynamic therapy. Biomaterials. 2013; 34: 4643-54.
43. Lin J, Wang S, Huang P, Wang Z, Chen S, Niu G, et al. Photosensitizer-loaded gold vesicles with strong plasmonic coupling effect for imaging-guided photothermal/photodynamic therapy. ACS Nano. 2013; 7: 5320-9.
44. Xiang L, Da X, Gu H, Yang D, Yang S, Zeng L, et al. Real-time optoacoustic monitoring of vascular damage during photodynamic therapy treatment of tumor. J Biomed Opt. 2007; 12: 014001.
45. Zackrisson S, van de Ven SMWY, Gambhir SS. Light in and sound out: emerging translational strategies for photoacoustic imaging. Cancer Res. 2014; 74: 979-1004.
46. Yoon T-J, Cho Y-S. Recent advances in photoacoustic endoscopy. World J Gastrointest Endosc. 2013; 5: 534-9.
47. Wang B, Su JL, Karpiouk AB, Sokolov KV, Smalling RW, Emelianov SY. Intravascular photoacoustic imaging. IEEE J Quantum Electron. 2010; 16: 588-99.
48. Heijblom M, Piras D, Xia W, van Hespen JCG, Klaase JM, van den Engh FM, et al. Visualizing breast cancer using the Twente photoacoustic mammoscope: What do we learn from twelve new patient measurements? Opt Express. 2012; 20: 11582.
49. de la Zerda A, Paulus YM, Teed R, Bodapati S, Dollberg Y, Khuri-Yakub BT, et al. Photoacoustic ocular imaging. Opt Lett. 2010; 35: 270-2.
50. Wilson KE, Bachawal SV, Tian L, Willmann JK. Multiparametric spectroscopic photoacoustic imaging of breast cancer development in a transgenic mouse model. Theranostics. 2014; 4: 1064-71.